News

Swiss biopharmaceutical company Actelion has reported that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, has issued a positive opinion

Centocor Ortho Biotech, a wholly-owned subsidiary of Johnson & Johnson, has received the FDA approval for its Simponi for the treatment of moderately to severely active rheumatoid arthritis,

Ridge Diagnostics, a neurodiagnostic company commercializing a proprietary blood test for depression or major depressive disorder, has received a Phase II, National Science Foundation, Small Business Innovation Research

2009 Outlook Looking forward to 2009, Bristol-Myers reaffirmed its GAAP per share earnings guidance of $1.58 – $1.73 and non-GAAP earnings outlook of $1.85 – $2.00 per share.

According to Patheon, Oros is a specialized drug delivery technology used to achieve the controlled release of active drug substances. When a patient swallows an Oros tablet, water

The contract is with a hospital that currently receives nighttime and weekend service. It is also the second hospital to opt for weekday daytime service from CTS. Each

Under the agreement, American CareSource will make available a complement of ancillary healthcare services to members of HealthMarkets’s subsidiaries through its ancillary care services network of providers. David

NextBio offers the life sciences enterprise secure data access, knowledge discovery and collaboration tools, and enterprise integration capabilities for seamless correlation of internal research data. Saeid Akhtari, co-founder

In this role, Dr Scaife will lead the development of Contrave, which is on track for submission to the FDA in the first half of 2010. Prior to